321 related articles for article (PubMed ID: 35440717)
1. Delivering precision oncology to patients with cancer.
Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
[TBL] [Abstract][Full Text] [Related]
2. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
3. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.
Casolino R; Beer PA; Chakravarty D; Davis MB; Malapelle U; Mazzarella L; Normanno N; Pauli C; Subbiah V; Turnbull C; Westphalen CB; Biankin AV
CA Cancer J Clin; 2024; 74(3):264-285. PubMed ID: 38174605
[TBL] [Abstract][Full Text] [Related]
4. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
5. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
6. Genomic profiling in oncology clinical practice.
Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the potential of reverse-phase protein array technology: Advancing precision oncology strategies.
Masuda M; Nakagawa R; Kondo T
Cancer Sci; 2024 May; 115(5):1378-1387. PubMed ID: 38409909
[TBL] [Abstract][Full Text] [Related]
8. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer.
Bottosso M; Mosele F; Michiels S; Cournède PH; Dogan S; Labaki C; André F
ESMO Open; 2024 Mar; 9(3):102247. PubMed ID: 38401248
[TBL] [Abstract][Full Text] [Related]
9. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
10. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
11. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H; Lee S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
[TBL] [Abstract][Full Text] [Related]
12. Innovative trial design in precision oncology.
Tsimberidou AM; Müller P; Ji Y
Semin Cancer Biol; 2022 Sep; 84():284-292. PubMed ID: 33022355
[TBL] [Abstract][Full Text] [Related]
13. Knowledge base toward understanding actionable alterations and realizing precision oncology.
Takeuchi S; Okuda S
Int J Clin Oncol; 2019 Feb; 24(2):123-130. PubMed ID: 30542800
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
Akhoundova D; Rubin MA
Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics workflows for clinical applications in precision oncology.
Jäger N
Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
[TBL] [Abstract][Full Text] [Related]
16. Pediatric oncology enters an era of precision medicine.
Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
[TBL] [Abstract][Full Text] [Related]
17. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
Madhavan S; Subramaniam S; Brown TD; Chen JL
Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Reitsma M; Fox J; Borre PV; Cavanaugh M; Chudnovsky Y; Erlich RL; Gribbin TE; Anhorn R
J Manag Care Spec Pharm; 2019 May; 25(5):601-611. PubMed ID: 30632889
[TBL] [Abstract][Full Text] [Related]
19. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]